0001493152-18-010156.txt : 20180718
0001493152-18-010156.hdr.sgml : 20180718
20180718200513
ACCESSION NUMBER: 0001493152-18-010156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180716
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bonstein Sara
CENTRAL INDEX KEY: 0001604019
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54318
FILM NUMBER: 18959339
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc
CENTRAL INDEX KEY: 0001444307
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980573252
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 5820 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 210-7333
MAIL ADDRESS:
STREET 1: 5820 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: NetVentory Solutions, Inc.
DATE OF NAME CHANGE: 20080902
4
1
ownership.xml
X0306
4
2018-07-16
0
0001444307
ONCOSEC MEDICAL Inc
ONCS
0001604019
Bonstein Sara
3565 GENERAL ATOMICS COURT #100
SAN DIEGO
CA
92121
0
1
0
0
CFO/COO
Common Stock
2018-07-16
4
A
0
625000
A
625000
D
Common Stock
2018-07-16
4
F
0
135485
1.34
D
489515
D
On July 16, 2018, the reporting person was awarded 625,000 RSUs pursuant to an employment inducement award. 312,500 of the RSUs vested and converted to ONCS stock on July 16, 2018, and the remaining 312,500 RSUs vest in equal quarterly installments over the next two years, such that the award will be fully vested on July 16, 2020.
Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
In connection with the vesting of 312,500 RSUs on July 16, 2018, a total of 135,485 shares were withheld by the Company from such RSUs in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such withholding, which was conducted automatically in accordance with the issuer's corporate policies.
/s/ Sara M. Bonstein
2018-07-18